explore -WSS

explore

author：Wikipedia 2025-09-30 00:51:44 - browse：74889

Two boxes of Humira and a Humira pen on the side — first opinion coverage from STAT — David J. Phillip/AP

It’s been one year since the launch of the first adalimumab biosimilar for Humira in the United States, which was followed by eight additional adalimumab biosimilar launches. These nine FDA-approved products offer lower-cost alternatives to the world’s bestselling drug, Humira, used to treat rheumatoid arthritis, Crohn’s disease, and other autoimmune disorders. This made 2023 a watershed year for millions of U.S. patients paying too much for their necessary medications.

But so far, that vision hasn’t come to fruition, because policymakers haven’t taken the action necessary to be sure these lower-cost products are accessible for patients. If they fail to act, the U.S. health care system could lose up to $133 billion in savings and leave patients without access to the medicines they need.

Biosimilars are safe and effective treatments referencing biologic drugs. They are market disruptors, forcing lower prices for biologic medicines. The cost savings from reference biologic products begins almost immediately when biosimilars enter the market and continues over time.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： DIEP, the 'gold standard' of breast reconstruction, is under threat
Next article： How redistricting in 6 states could affect who controls Congress

WSS

In rare move, senator releases unverified FBI source report alleging Biden bribe

Headers linked to memory issues, raising questions about soccer safety as the World Cup kicks off

A woman pleads guilty to fire that kept a Wyoming abortion clinic from opening for a year

Caribou posts encouraging results on off

When a patient nears the end, a feared therapy can comfort

A woman pleads guilty to fire that kept a Wyoming abortion clinic from opening for a year

focus

explore

hotspot

What does generative AI mean for health care? We asked experts

Scientists grapple with ethics of stem cell research

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Headers linked to memory issues, raising questions about soccer safety as the World Cup kicks off

Drug repurposing or repositioning? The language matters

House panel to mark up pandemic

After affirmative action ruling, medical educators look to 'holistic review'

After a decade, new Gardasil ad campaign gets it (mostly) right

Hollywood unions extend contract negotiations for actors

The PBM ad wars are taking over Washington, D.C.

explore

Submersible on Titanic tour reported missing off Newfoundland with 5 people aboard

Trump seeks lengthy delay of classified docs trial, citing upcoming election

The stock market has soared this year, but will it last? Experts weigh in

How a Boston hospital is priming medical residents to use GPT

5 dead in mass shooting on Caribbean island of St. Vincent: Police

Dementia risk linked to living in disadvantaged areas: Study

focus

focus

Wikipedia

hotspot